Abcam (ABCM) Change In Inventory : $-15.2 Mil (TTM As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Abcam Change In Inventory?

Abcam's change in inventory for the quarter that ended in Jun. 2023 was $-2.7 Mil. It means Abcam's inventory increased by $2.7 Mil from Dec. 2022 to Jun. 2023 .

Abcam's change in inventory for the fiscal year that ended in Dec. 2022 was $-9.0 Mil. It means Abcam's inventory increased by $9.0 Mil from Jun. 2020 to Dec. 2022 .

Abcam's Total Inventories for the quarter that ended in Jun. 2023 was $83.7 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Abcam's Days Inventory for the quarter that ended in Jun. 2023 was 249.19.

Inventory Turnover measures how fast the company turns over its inventory within a year. Abcam's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.73.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Abcam's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.32.

Abcam Change In Inventory Historical Data

The historical data trend for Abcam's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Change In Inventory Chart

Abcam Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Dec22

Change In Inventory

Get a 7-Day Free Trial

-2.69

-7.71

-7.73

-1.38

-9.01

Abcam Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Change In Inventory	Get a 7-Day Free Trial															-5.38	-	3.57	-12.55	-2.65

Abcam Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-15.2 Mil.

Abcam (NAS:ABCM) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Abcam's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	83.269	/	60.985	*	365 / 2
	=	249.19

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Abcam's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	60.985	/	83.269
	=	0.73

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Abcam's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	83.269	/	256.566
	=	0.32

Abcam Change In Inventory Related Terms

Thank you for viewing the detailed overview of Abcam's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Abcam (ABCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (NAS:ABCM) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX

Website

https://www.abcam.com

Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.